Table 1 Characteristics of HCC patients.

From: PD-L1+MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment

Characteristics of patients

Number/Value

Total number

122

Age (years)

63.8 ± 9.4 (mean ± SD)

Gender (Male:Female)

83:39

Etiology

 B

19

 C

75

 B+C

9

 NBNC

19

 alcohol

11

 NASH

2

 PBC

1

 unknown

5

Child-Pugh Class

 A

73

 B

47

 C

2

TNM UICC7

 I

48

 II

55

 IIIA

4

 IIIB/IIIC/IVA

0

 IVB

15

Treatment

 OP

14

 RFA

9

 TACE

77

 RT

10

 TACE+RFA

5

 HAIC

2

 sorafenib

3

 BSC

2

Laboratory Data

 T-BIL (mg/dL)

1.15 (0.3–3.5)

 AST (IU/L)

46 (15–145)

 ALT (IU/L)

37 (13–135)

 ALB (g/dL)

3.3 (2.0–4.3)

 PT (%)

82.2 (53.4–120)

 WBC (/L)

3900 (1600–13500)

 Hb (g/dL)

13 (9.3–16.2)

 PLT (103/L)

100 (39–318)

 AFP (ng/mL)

39.8 (3.1–17166)

 AFP-L3 (%)

11 (0.5–83.5)

 PIVKA II (mAU/mL)

45 (9–20300)

  1. Hepatitis B virus (B), heatitis C virus (C), operation (OP), radiofrequency ablation (RFA), trans arterial chemo-embolization (TACE), radiation therapy (RT), hepatic artery infusion chemotherapy (HAIC), best supportive care (BSC), total bilirubin (T-BIL), aspirate aminotransferase (AST), alanine aminotransferase (ALT), albumin (ALB), prothrombin time (PT), white blood cell (WBC), hemoglobin (Hb), platelet (PLT), alpha-fetoprotein (AFP), prothrombin induced by vitamin K absence II (PIVKA- II).
Back to article page